Meditor Group Ltd ESPR Holdings History

Number of Shares
3.79 Mil
Current Holdings Value*
$6.26 Mil
% of Portfolio
12.99%
Total Estimate Gain
$-146.75 Mil
% of Total Estimate Gain
-96.43%

Meditor Group Ltd's Esperion Therapeutics Inc Holding Summary

As of 2024-09-30, Meditor Group Ltd held 3.79 Mil shares of Esperion Therapeutics Inc(ESPR), totaling $6.26 Mil. This investment constitutes 12.99% of their stock portfolio, and Meditor Group Ltd now holds 1.93% of the outstanding Esperion Therapeutics Inc(ESPR) stock.

The initial trade took place in 2018Q2. And since then Meditor Group Ltd has made 4 purchases of ESPR, at an average price of $34.06, for a total of 4.47 Mil shares. In addition, there have been 2 sales at an average price of $1.81 for 677,535.00 shares. Based on historical transaction data and ESPR's current price of $1.11, Meditor Group Ltd's estimated gain on his ESPR holdings is $-146.75 Mil, reflecting a -96.43% gain to date.

Meditor Group Ltd ESPR ($1.11) Holding Chart

Meditor Group Ltd ESPR ($1.11) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1